CompletedNot Applicable

Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO

Egypt132 participantsStarted 2020-07-04

Plain-language summary

comparing the outcome of low-intensity shock wave therapy (Li-SWT) versus solifenacin on persistent storage symptoms after transurethral surgery for benign prostatic obstruction (BPO)

Who can participate

Age range50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Ability to give informed consent and reply to questionnaires.
✓. Average urgency episodes per 24 hrs ≥ 1 and average daytime frequency ≥ 8 during the baseline 3-day voiding diary.
✓. Relief of BOO as proved by non-invasive uroflowmetry, pressure flow study (PFS) or urethrocystoscopy.

Exclusion criteria

✕. Untreated UTI.
✕. BOO such as bladder neck contracture (BNC), residual obstructing adenoma or urethral stricture.
✕. Neurogenic lower urinary tract dysfunction (LUTD).
✕. Uncontrolled diabetes mellitus.
✕. Depression or any psychogenic disorders.
✕. Prior radiation therapy to the pelvic area.
✕. History of prostate cancer, bladder tumor or intravesical Bacillus Calmette Guerin (BCG) therapy.
✕. Poor coagulopathy.

What they're measuring

The percent change in overactive bladder symptoms score (OABSS)

Timeframe: approximately 20 months

Percent of responders

Timeframe: approximately 20 months

The numerical change in overactive bladder symptoms score (OABSS)

Timeframe: approximately 2 years.

3-day voiding diary

Timeframe: approximately 2 years.

Incidence of adverse events associated with treatment

Timeframe: approximately 18 months

Trial details

NCT IDNCT04437108

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-12

View on ClinicalTrials.gov More Overactive Bladder trials